Inventor · disambiguated record
Zice Fu
Also filed as: FU ZICE
29 granted patents·6 pending applications·365 citations·filing 2003–2023
97Inventor score
Top patents by PatentIndex Score
35 records- 0198US10344016B2Bromotriazole intermediatesAMGEN INC·Filed 2018·Granted Jul 9, 2019·8 cites·5 claims
- 0298US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0397US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0497US10058550B2Methods of treating heart failureAMGEN INC·Filed 2017·Granted Aug 28, 2018·13 cites·81 claims
- 0597US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0697US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0797US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0895US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0995US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 1095US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1195US7541383B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2007·Granted Jun 2, 2009·86 cites·24 claims
- 1292US7375102B2Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted May 20, 2008·27 cites·24 claims
- 1391US7939538B2Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseasesAMGEN INC·Filed 2005·Granted May 10, 2011·20 cites·23 claims
- 1490US10150760B2Compounds for use in preparing heterocyclic triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Dec 11, 2018·8 cites·29 claims
- 1589US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 1688US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 1788US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1888US7321001B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2003·Granted Jan 22, 2008·39 cites·25 claims
- 1987US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 2086US8030354B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Oct 4, 2011·11 cites·96 claims
- 2181US7572934B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Aug 11, 2009·5 cites·70 claims
- 2280US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 2380US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 2477US7271271B2Imidazolo-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted Sep 18, 2007·3 cites·14 claims
- 2574US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 2673US8748462B2Spirocyclic GPR40 modulatorsBROWN SEAN P·Filed 2009·Granted Jun 10, 2014·2 cites·25 claims
- 2773US8003648B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2009·Granted Aug 23, 2011·1 cites·10 claims
- 2870US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
- 2967US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 3065US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 3164US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 3256US7714008B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2007·Granted May 11, 2010·0 cites·11 claims
- 3347US8022061B2N-aryl pyrazole compounds, compositions, and methods for their useAMGEN INC·Filed 2007·Granted Sep 20, 2011·0 cites·15 claims
- 3445US11021493B21,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jun 1, 2021·0 cites·33 claims
- 3531US8785468B2Phenylalanine amide derivatives useful for treating insulin-related diseases and conditionsDU XIAOHUI·Filed 2010·Granted Jul 22, 2014·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Zice Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →